India News: The drug regulator’s subject expert committee (SEC) on Covid vaccines on Wednesday recommended full authorisation for the two widely used jabs —...
https://timesofindia.indiatimes.com/india/covishield-covaxin-to-get-full-approval-but-wont-be-retailing/articleshow/89005008.cms#timesofindia #India
Du måste logga in före du kommenterar